These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33490001)

  • 1. Hemostatic Testing in Critically Ill Infants and Children.
    Nair AB; Parker RI
    Front Pediatr; 2020; 8():606643. PubMed ID: 33490001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles of hemostasis in children: models and maturation.
    Guzzetta NA; Miller BE
    Paediatr Anaesth; 2011 Jan; 21(1):3-9. PubMed ID: 20849450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global assays of fibrinolysis.
    Ilich A; Bokarev I; Key NS
    Int J Lab Hematol; 2017 Oct; 39(5):441-447. PubMed ID: 28497494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Overall Hemostatic Potential (OHP) Assay.
    Curnow J
    Methods Mol Biol; 2017; 1646():523-531. PubMed ID: 28804852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Developing Balance of Thrombosis and Hemorrhage in Pediatric Surgery: Clinical Implications of Age-Related Changes in Hemostasis.
    Achey MA; Nag UP; Robinson VL; Reed CR; Arepally GM; Levy JH; Tracy ET
    Clin Appl Thromb Hemost; 2020; 26():1076029620929092. PubMed ID: 32584601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new assay for global fibrinolysis capacity (GFC): Investigating a critical system regulating hemostasis and thrombosis and other extravascular functions.
    Amiral J; Laroche M; Seghatchian J
    Transfus Apher Sci; 2018 Feb; 57(1):118-126. PubMed ID: 29525568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between Thrombin Generation, Standard Coagulation Assays, and Viscoelastic Assays for Hemostatic Assessment in Critically Ill Children.
    Thomas KA; Shea SM; Saini A; Muszynski JA; Spinella PC
    J Appl Lab Med; 2022 Sep; 7(5):1108-1119. PubMed ID: 35587709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A guide for diagnosis of patients with arterial and venous thrombosis.
    Quinn C; Hill J; Hassouna H
    Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the laboratory analyses of bleeding disorders.
    Chitlur M
    Thromb Res; 2012 Jul; 130(1):1-6. PubMed ID: 22483776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
    Muthard RW; Welsh JD; Brass LF; Diamond SL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis.
    Potze W; Adelmeijer J; Porte RJ; Lisman T
    Thromb Res; 2015 May; 135(5):1012-6. PubMed ID: 25746364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemostatic system.
    Stassen JM; Arnout J; Deckmyn H
    Curr Med Chem; 2004 Sep; 11(17):2245-60. PubMed ID: 15379710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma.
    Xin KZ; Chang WC; Ovanesov MV
    Thromb Res; 2016 Apr; 140():132-139. PubMed ID: 26632515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy in liver disease: a balancing act.
    Kujovich JL
    Hematology Am Soc Hematol Educ Program; 2015; 2015():243-9. PubMed ID: 26637729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central role of thrombin in bleeding disorders.
    Negrier C; Shima M; Hoffman M
    Blood Rev; 2019 Nov; 38():100582. PubMed ID: 31164248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults.
    Ignjatovic V; Pelkmans L; Kelchtermans H; Al Dieri R; Hemker C; Kremers R; Bloemen S; Karlaftis V; Attard C; de Laat B; Monagle P
    Thromb Res; 2015 Dec; 136(6):1303-9. PubMed ID: 26522267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.